-
Je něco špatně v tomto záznamu ?
The development of a butyrylcholinesterase porous pellet for innovative detection of cholinesterase inhibitors
J. Zeman, D. Vetchý, A. Franc, S. Pavloková, V. Pitschmann, L. Matějovský,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- butyrylcholinesterasa chemie MeSH
- celulosa chemie MeSH
- cholinesterasové inhibitory chemie MeSH
- enzymy imobilizované chemie MeSH
- fysostigmin chemie MeSH
- lékové formy MeSH
- nosiče léků chemie MeSH
- pomocné látky chemie MeSH
- poréznost MeSH
- povidon chemie MeSH
- sarin MeSH
- silikáty chemie MeSH
- sloučeniny hliníku chemie MeSH
- sloučeniny hořčíku chemie MeSH
- tvrdost MeSH
- Publikační typ
- časopisecké články MeSH
The aim of the presented research was the preparation of an innovative carrier with significantly improved properties for the fast and sensitive detection of cholinesterase inhibitors such as nerve agents. This innovative carrier was in the form of spherical pellets containing different amounts of Neusilin. Neusilin is a synthetic and amorphous form of magnesium aluminometasilicate with a high specific surface area, and the immobilized enzyme butyrylcholinesterase with an activity of 50nkat·g-1. Pellets were prepared by the extrusion-spheronization method and dried in a hot air oven under two conditions - at 30°C for 72h and at 60°C for 24h. Dried pellets were consequently impregnated with a solution containing butyrylcholinesterase. Impregnated pellets were evaluated for their quality parameters, enzymatic activity and inhibition. Activity and inhibition were tested according to the standard Ellman's method. It was observed that the addition of Neusilin significantly increased the hardness, intraparticular porosity, sphericity and activity of the carriers as well as intensity of the color transition. Therefore it is shown that these carriers have unquestionable advantages over common carriers of their kind. Drying temperatures have been shown to have no effect on properties of pellets except for a change in their size. Results were confirmed by statistical evaluation using ANOVA and PCA.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033722
- 003
- CZ-PrNML
- 005
- 20181008122152.0
- 007
- ta
- 008
- 181008s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2017.09.015 $2 doi
- 035 __
- $a (PubMed)28917965
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Zeman, Jiří $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1946/1, Brno, Czech Republic.
- 245 14
- $a The development of a butyrylcholinesterase porous pellet for innovative detection of cholinesterase inhibitors / $c J. Zeman, D. Vetchý, A. Franc, S. Pavloková, V. Pitschmann, L. Matějovský,
- 520 9_
- $a The aim of the presented research was the preparation of an innovative carrier with significantly improved properties for the fast and sensitive detection of cholinesterase inhibitors such as nerve agents. This innovative carrier was in the form of spherical pellets containing different amounts of Neusilin. Neusilin is a synthetic and amorphous form of magnesium aluminometasilicate with a high specific surface area, and the immobilized enzyme butyrylcholinesterase with an activity of 50nkat·g-1. Pellets were prepared by the extrusion-spheronization method and dried in a hot air oven under two conditions - at 30°C for 72h and at 60°C for 24h. Dried pellets were consequently impregnated with a solution containing butyrylcholinesterase. Impregnated pellets were evaluated for their quality parameters, enzymatic activity and inhibition. Activity and inhibition were tested according to the standard Ellman's method. It was observed that the addition of Neusilin significantly increased the hardness, intraparticular porosity, sphericity and activity of the carriers as well as intensity of the color transition. Therefore it is shown that these carriers have unquestionable advantages over common carriers of their kind. Drying temperatures have been shown to have no effect on properties of pellets except for a change in their size. Results were confirmed by statistical evaluation using ANOVA and PCA.
- 650 _2
- $a sloučeniny hliníku $x chemie $7 D017607
- 650 _2
- $a butyrylcholinesterasa $x chemie $7 D002091
- 650 _2
- $a celulosa $x chemie $7 D002482
- 650 _2
- $a cholinesterasové inhibitory $x chemie $7 D002800
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a enzymy imobilizované $x chemie $7 D004800
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a tvrdost $7 D006244
- 650 _2
- $a sloučeniny hořčíku $x chemie $7 D017616
- 650 _2
- $a fysostigmin $x chemie $7 D010830
- 650 _2
- $a poréznost $7 D016062
- 650 _2
- $a povidon $x chemie $7 D011205
- 650 _2
- $a sarin $7 D012524
- 650 _2
- $a silikáty $x chemie $7 D017640
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vetchý, David $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1946/1, Brno, Czech Republic. Electronic address: vetchy@email.cz.
- 700 1_
- $a Franc, Aleš $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1946/1, Brno, Czech Republic.
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackého 1946/1, Brno, Czech Republic.
- 700 1_
- $a Pitschmann, Vladimír $u Oritest Ltd., Nábřežní 90/4, Prague, Czech Republic.
- 700 1_
- $a Matějovský, Lukáš $u Faculty of Environmental Technology, University of Chemistry and Technology, Technická 5, Prague, Czech Republic.
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 109, č. - (2017), s. 548-555
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28917965 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181008122638 $b ABA008
- 999 __
- $a ok $b bmc $g 1339567 $s 1030716
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 109 $c - $d 548-555 $e 20170913 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20181008